Funded Data and Analytics Startups in Denver
Denver’s data-and-analytics funding here is dominated by one disclosed outlier: Urban Sky’s $30M Series B on 2025-02-06, while the next-largest disclosed r…
Denver’s data-and-analytics funding here is dominated by one disclosed outlier: Urban Sky’s $30M Series B on 2025-02-06, while the next-largest disclosed rounds are much lower ($22M ForceMetrics on 2024-10-16, then $10M Govly on 2023-11-02 and $10M Albedo on 2021-04-22). The disclosed amounts also show a tight lower band: multiple rounds sit at $2M–$3M (PAIRIN $2M on 2023-02-01; Highwing $3M on 2021-12-13), with only small entries in the hundreds of thousands (Demand IQ $300K on 2021-11-18; TCarta $100K on 2022-05-09).
Timing clusters around mid-range years rather than being evenly spread: the oldest row is HarperDB (2020-12-08, $2M) and the newest is Urban Sky (2025-02-06). Stage classifications are fragmented—“Series Unknown” appears in two entries (ForceMetrics 2024-10-16 $22M; PAIRIN 2023-02-01 $2M; plus RxRevu 2021-06-28 $8M, with a blank stage label), and “undisclosed” amounts appear in two entries (Nucla 2024-02-01; bluDOT 2022-11-01).
Most recent rounds
15 shownRelated listings
Frequently asked
What stands out as the largest disclosed round in Denver data and analytics, and how far ahead is it of the rest?
Urban Sky’s disclosed $30M Series B (2025-02-06) is the only disclosed round at $30M in this set; the next-largest disclosed amount is $22M from ForceMetrics (2024-10-16), followed by $10M rounds from Govly (2023-11-02) and Albedo (2021-04-22).
How concentrated are the recent rounds by date—do the most recent entries cluster within a specific window?
Five of the 15 rows fall within 2024–2025 (Urban Sky 2025-02-06 $30M; ForceMetrics 2024-10-16 $22M; Nucla 2024-02-01 undisclosed; plus PAIRIN 2023-02-01 $2M is outside that window), indicating heavier activity in late 2024 and early 2025 compared with earlier years.
Are there stage-mix patterns, especially around missing or unspecified round types?
Stage labeling is incomplete: “Series Unknown”/unspecified appears in three entries with disclosed amounts (ForceMetrics 2024-10-16 $22M; PAIRIN 2023-02-01 $2M; RxRevu 2021-06-28 $8M with a blank stage label). Separate from that, two entries have undisclosed amounts (Nucla 2024-02-01; bluDOT 2022-11-01).
Which disclosed amounts form the low-end cluster, and what are the notable small-ticket rounds?
Several disclosed rounds cluster in the $2M–$3M range (PAIRIN $2M on 2023-02-01; Highwing $3M on 2021-12-13), while smaller outliers include TCarta at $100K (2022-05-09) and Demand IQ at $300K (2021-11-18).
Do any companies appear multiple times in this list via different transaction types, suggesting a follow-on market pattern?
Most entries are single-round events by company name, but two rows reflect different transaction structures rather than a primary equity round: Assignar is labeled “Secondary Market” at $17M (2021-11-08), and Highwing is “Debt Financing” at $3M (2021-12-13), both distinct from the more common Series/seed-style labels.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.